Sarcopenic Obesity is a complex pathological condition characterized by the simultaneous presence of excessive body fat mass and reduced skeletal muscle mass and strength, often masked by a seemingly normal body weight. This dual diagnosis represents a particularly adverse body composition profile that significantly increases the risk of metabolic disease, functional decline, and frailty. The hormonal dysregulation associated with obesity accelerates the muscle loss characteristic of sarcopenia.
Origin
The term is a clinical construct derived from gerontology and endocrinology, combining the Greek sarx (flesh) and penia (loss) with the definition of obesity. It gained prominence as researchers recognized that body weight alone was an insufficient indicator of metabolic health, especially in aging populations.
Mechanism
This condition is driven by a vicious cycle of chronic, low-grade inflammation and insulin resistance, which both contribute to muscle protein catabolism and impaired anabolic signaling. Excess adipose tissue secretes pro-inflammatory cytokines that directly inhibit muscle protein synthesis and promote lipolysis, while reduced muscle mass further exacerbates insulin resistance, leading to a progressive deterioration of metabolic and physical function.
Lifestyle interventions can protect cognitive function during ADT by targeting the metabolic and inflammatory pathways that link hormone loss to neuronal stress.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.